[Adjuvant chemotherapy in operable breast cancer].
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001365:Axilla; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D002369:Castration; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008408:Mastectomy; D008558:Melphalan / Q000627:therapeutic use; D008593:Menopause; D051379:Mice; D009367:Neoplasm Staging; D011379:Prognosis; D013629:Tamoxifen / Q000627:therapeutic use
D000970:Antineoplastic Agents; D013629:Tamoxifen; D003520:Cyclophosphamide; D008558:Melphalan
Adjuvante Chemotherapie beim operablen Mammakarzinom.